FINAL EXAM Flashcards
Relative Risk
Ratio between probability of event in exposed vs. not exposed groups
Randomized Control Trials (RCT)
-Subjects randomly assigned to treatment or control groups
-Study done with follow-ups and results compared
-Used to test efficacy and effectiveness of different interventions within a sample population
Efficacy Trials
*high internal validity/control
-Whether an intervention works in people who receive it
-“What happens when you exercise”
-Strict, standardized, supervised, research setting
*whether intervention works under ideal circumstances
Effectiveness Trials
*high external validity/control
-Whether an intervention works in people who have been offered it
-“How to get people to increase and sustain exercise”
-Does it work in pragmatic/real-world settings
-Flexible, unsupervised, everyday clinical setting
*what must be done to change behaviours towards working to achieve goals
Prospective Cohort Trials (Strengths and Weaknesses)
-Follows a group of individuals (cohorts) over time who differ in terms of factors under study to determine how these factors affect rates of an outcome
-Group of interest vs. comparison group, follow over time and compare outcomes
Strengths: large sample, generalizability, multiple outcomes can be studied
Weaknesses: expensive, confounding, changes in exposure of time
Prospective Study vs. Retrospective Study
Prospective: participants enrolled before they develop disease/outcome
Retrospective: particpants enrolled who already have the disease/outcome
Canadian 24-Hr Movement Guidelines (First-Time Observations)
Main idea= whole day matters (physical activity, sedentary behaviour and sleep)
First-time observations:
1. Recognized health benefits of LPA
2. Specific recommendations for sedentary behaviour (including screen time)
3. Removal of 10 min bout requirement for MVPA (all counts)
4. Recommendations for sleep duration and quality
5. That the composition of movement behaviours (sleep, sedentary behaviour and physical activity) across entire 24-hour day is associated with health**
Principle Assertion of Guidelines
Past guidelines= behaviours in isolation/all separate, focus on single behaviour (as long as one met rest doesn’t matter)
Current guidelines= behaviours co-exist and influence one another (all parts matter, if one goes up another goes down)
- Move more
- Reduce sedentary time
- Sleep well
MVPA Definition
Moderate intensity= 3.0-5.9 METS on absolute scale, 5-6 on scale out of 10 (can talk but not sing)
Vigorous intensity= greater than or equal to 6.0 METS, 7-8+ on scale out of 10 (can only say a few words)
- MVPA is associated with substantial risk reduction
- Any amount counts
- Reallocating more time into MVPA from other behaviours is associated with health benefits
*U.S. uses intensity (MET-minutes), Canada uses time (mins)
MVPA Recommendations
- MVPA accumulation of at least 150 mins/week (no 10 min bouts required)
- Muscle strengthening activities for major muscle groups at least 2x/week
- For 65+ do physical activities that challenge balance
1) No lower threshold for benefit
2) No upper threshold (no increased risk at high levels)
3) No obvious best amount and intensity doesn’t matter (dose-response)
LPA Definiton
Light intensity= 1.5-2.9 METS on absolute scale, less than 5 out of 10
Includes daily living activities, casual walking, chores, gardening
*U.S.= no recommendation for LPA
LPA Recommendations
- Several hours of LPA including standing (no specific time recommendation like MVPA- not enough evidence)
*all intensities of objectively measured PA, including LPA, are associated with substantially reduced risk of mortality in a dose-response manner
Sedentary Behaviour Recommendations
- Limit sedentary time to 8 hours or less, including:
- No more than 3 hours of recreational screen time
- Breaking up long periods of sitting as often as possible
Sedentary= 1.1-1.4 METS (sleep= 1 MET)
LPA and MVPA on Cancer Risk
LPA: 30 mins/day more significant than 30 mins/day of MVPA in reducing risk of cancer
MVPA: 30 mins/day has no effect
LPA and MVPA on CVD Risk
Both LPA and MVPA significantly decrease risk of CVD mortality